The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. - Wikidata - awgldk - TriplyDB

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

http://www.wikidata.org/entity/Q42716720

about

The ketogenic diet as a treatment paradigm for diverse neurological disorders Ketogenic diet in neuromuscular and neurodegenerative diseases Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options Ketogenic diet for obesity: friend or foe?Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease Harnessing the power of metabolism for seizure prevention: focus on dietary treatments Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway.Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic Review Ketone bodies as signaling metabolites.Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice.Potential therapeutic use of the ketogenic diet in autism spectrum disorders Ketogenic diets: from cancer to mitochondrial diseases and beyond.Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.β-hydroxybutyrate: much more than a metabolite Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage Ketogenic diets, mitochondria, and neurological diseases.Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.The ketogenic diet: metabolic influences on brain excitability and epilepsy.Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation.Hypothalamic hormones and metabolism.Ketogenic diets: new advances for metabolism-based therapies.The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.Autophagy and amino acid metabolism in the brain: implications for epilepsy.mTOR inhibition in epilepsy: rationale and clinical perspectives.A bioenergetics systems evaluation of ketogenic diet liver effects.How does the ketogenic diet work? Four potential mechanisms Ketogenesis contributes to intestinal cell differentiation.The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.Ketogenic Diet and Cancer-a Perspective.Ketogenic diet for epilepsy treatment.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.DEPDC5 as a potential therapeutic target for epilepsy.Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children

P2860

Q21129287-7B956ABD-7087-4321-BB89-CA0831927B43 Q21284703-1EB2FDA0-5424-40D7-A539-C0E851DE35BF Q22305852-13FCA8F4-37E1-4B78-A781-EC00E0C6D631 Q26824104-2B587F51-0F28-45C9-B93A-C33F10DF16BB Q26828498-E66577FC-4AE5-4042-8797-5818BA6FB810 Q26991869-67C58F8D-0469-4A01-87EF-A6E3F99DD4BC Q28480776-0A55561B-17BB-4063-B2A6-E0A8D3A23BAC Q30626751-28579261-08DC-4046-B35D-813A2CB23B9F Q33743850-6172545E-4A6C-43DC-9E9A-8F473E980EBD Q34252732-44BDC059-808F-4C8B-82F8-11F7AE1B774E Q34353543-8685BD7D-5B45-4C51-B359-B9CC0448830D Q34416405-3169BCD0-580F-46A3-B558-488FD97B33B3 Q34431317-5CE50856-C383-4864-ABB6-00FF5CE36899 Q34509699-F72BE205-AA0C-45FC-8097-EAC228F0B8AF Q35028378-9308302D-4A33-4084-BCB2-8418E4B99486 Q35234097-3A38D1A0-26A0-4048-9BDA-0BE8579092B0 Q35553084-5501A6ED-0487-4A67-AFFA-68B113B85501 Q36087987-D51C68FC-5D5D-452E-AAA6-D8030A247150 Q36196765-9A0B159A-DFC7-4B5D-BE8E-B418B097D238 Q36351072-36704D4E-6CB9-4BB3-A345-C80FA43C28F0 Q36501202-961E8AEC-F195-4D74-A12C-960D5D72048A Q37419781-E6CC5723-9D70-498F-BCD3-901DA7224DBE Q37597272-FE2E5166-F14F-4F11-AEC0-EB0337F56AA8 Q37653680-2ABAF1B9-B83E-4387-A7E1-36B64BDECB74 Q37705691-33E958AE-D2D8-44E0-A6C0-005861410F53 Q37920318-89D1CDAA-BDCD-4F4C-AC7B-CC582AFE0E2E Q37982950-ACD915B0-BFE9-4365-8DEE-489F51C4F401 Q38028872-72E79F30-67F0-4399-A572-8B6AEFE44896 Q38242039-C51FC237-AEFF-49E6-814A-1E10F9DEBD93 Q38336887-30469A5A-25EB-4D38-898C-9AD4CA1CA33E Q38370749-79F9D361-2378-4353-80E1-3DD9C7AB8C95 Q38582924-CAC02BDE-D113-4835-B6F5-CB2732A9F24F Q38726932-C25A46D3-B9DB-49C1-9182-E80E6B7AE34C Q38755497-0BAFB082-9EF9-4F16-A060-6FB13B8EEC75 Q38936285-4FE86C58-B39B-4E1B-B68D-8445C7D586BE Q38985397-723055A7-DAE8-4D4A-83B0-CE2C26E14244 Q38994919-B4101939-FA2C-415B-99DE-286F1F36CBA6 Q39126886-3D4B7964-DCA4-45ED-8BB5-6B0F13FE31C4 Q39239920-D40F8902-E064-4B22-932E-94F8B28D461E Q41218069-79F39547-945E-4CF4-800A-489C1F567DCA

P2860

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

http://www.wikidata.org/entity/Q42716720

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

@en

The ketogenic diet inhibits the mammalian target of rapamycin

@nl

type

label

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

@en

The ketogenic diet inhibits the mammalian target of rapamycin

@nl

prefLabel

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

@en

The ketogenic diet inhibits the mammalian target of rapamycin

@nl

P1433

Q42716720-B478586F-FEB1-4D93-85DC-26C177257956

P1476

Q42716720-1402B8A0-7E14-4DFC-968A-8C96E83A5DD1

P2093

Q42716720-2337BEFF-0CE8-4D82-9093-B3C2B80869FF

Q42716720-4C037584-8420-4ADA-B500-04B46550B9C4

Q42716720-8C88D60F-2AFA-423B-9E17-06710DB78AC8

Q42716720-9617C28E-18D7-4C35-A846-CFF239680197

Q42716720-C7424C2C-42CC-4FE5-999C-07CBB9C94ACE

P2860

Q42716720-04558281-35D4-497F-974C-057F7F207567

Q42716720-0934F37B-44B5-4E4E-BFB3-B1BFE135DB80

Q42716720-2C21FF0B-0EE9-4E7B-BABA-C67004E05646

Q42716720-34F3511E-1422-4703-84CD-7D3E97142C47

Q42716720-3EE0D138-8382-4610-B0F3-F523D5732F51

Q42716720-6C600EA0-35A4-4DEB-B564-2D66CCF14671

Q42716720-B8B02C0B-1F86-4A7D-B4B0-2680B45237D3

Q42716720-CB5CDE01-C31A-4017-893E-C3E92E79AEC0

Q42716720-CF5E9437-2A1D-45A2-9ACE-B53E219DE1C4

Q42716720-E508D52F-6E4B-4966-8BC9-323E98CA594C

P304

Q42716720-813F0C28-564E-4539-B3F0-93B1355C4114

P31

Q42716720-CBA3B0C4-327F-40B8-9B17-C83536BEC303

P356

Q42716720-285C2BBC-1057-40D7-8C03-D1CD433DD9A1

P433

Q42716720-23EB6A32-43BE-44C2-AC36-C42BA6825F67

P478

Q42716720-DD56FFD0-4F89-4B76-BE12-063AA667DAF5

P577

Q42716720-2FD712A4-ED31-4567-9BA6-2166B870989E

P5875

Q42716720-97428B11-F2B6-4AC0-A02D-872F970A2876

P698

Q42716720-D94EDACA-4C25-468F-95FB-9876B2E79C4B

P932

Q42716720-7941EC5D-B02B-4032-8867-A64045162D13

P356

J.1528-1167.2011.02981.X

P1433

P1476

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

@en

P2093

Kelvin A Yamada

http://www.w3.org/2001/XMLSchema#string

Liu Lin Thio

http://www.w3.org/2001/XMLSchema#string

Michael Wong

http://www.w3.org/2001/XMLSchema#string

Nicholas R Rensing

http://www.w3.org/2001/XMLSchema#string

Sharon S McDaniel

http://www.w3.org/2001/XMLSchema#string

P2860

The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year.

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies

Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet.

Calorie restriction and glucose regulation.

Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet.

Long-term outcomes of children treated with the ketogenic diet in the past.

Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model.

Chronic ketosis and cerebral metabolism.

P304

e7-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1528-1167.2011.02981.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50269782

http://www.w3.org/2001/XMLSchema#string

P698

21371020

http://www.w3.org/2001/XMLSchema#string

P932

3076631

http://www.w3.org/2001/XMLSchema#string